Enners, Salka

Referentin für Pharmakoepidemiologie, Apothekerin, Deutsches Arzneiprüfungsinstitut e. V. (DAPI), Berlin

Publications:

Use of fixed‑dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia

Masterthesis - Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave

Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012–2021

Increased Demand for Pharmaceutical Drugs Containing Potassium Iodide In Connection with the Russia-Ukraine Conflict

Verordnungsqualität oraler Fluorchinolone in den deutschen Bundesländern 2014 bis 2019

Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave

Infliximab And Etanercept Biosimilars And Originators: Learnings From Regional Market Dynamics In Germany

Impact On Antihypertensive Prescribing After The Dear Healthcare Professional Letter On Increased Risk Of Skin Cancer Related To Hydrochlorothiazide

Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave

Quality Appraisal of Ambulatory Oral Cephalosporin and Fluoroquinolone Use in the 16 German Federal States from 2014–2019

Changes in utilization of antihypertensive drugs following angiotensin receptor blocker product recalls in Germany

Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany

Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany

“Dear Doctor” Warning Letter (Rote-Hand-Brief) on Hydrochlorothiazide and Its Impact on Antihypertensive Prescription